MedPath

Risk Factors for Shoulder Joint Motion Restriction

Conditions
Breast Cancer Survivors
Interventions
Other: measurement of tissue stiffness (N/m)
Other: measurement of passive muscle tone (Hz)
Other: measurement of creep of tissue
Other: measurement of the range of shoulder joint motion
Other: measurement of skin temperature
Other: measurement of pain
Other: measurement of pain pressure threshold
Other: measurement of grip strength
Registration Number
NCT05386641
Lead Sponsor
Istanbul Medeniyet University
Brief Summary

In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment. Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living. The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
72
Inclusion Criteria
  • Women between the ages of 30-60
  • Having breast cancer treatment within 5 years
Exclusion Criteria
  • Not having agreed to participate in the study
  • Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Experimental Groupmeasurement of painBreast cancer survivors with shoulder joint motion restriction
Control groupmeasurement of skin temperatureBreast cancer survivors without shoulder joint motion restriction
Experimental Groupmeasurement of creep of tissueBreast cancer survivors with shoulder joint motion restriction
Experimental Groupmeasurement of the range of shoulder joint motionBreast cancer survivors with shoulder joint motion restriction
Experimental Groupmeasurement of tissue stiffness (N/m)Breast cancer survivors with shoulder joint motion restriction
Experimental Groupmeasurement of passive muscle tone (Hz)Breast cancer survivors with shoulder joint motion restriction
Control groupmeasurement of tissue stiffness (N/m)Breast cancer survivors without shoulder joint motion restriction
Control groupmeasurement of painBreast cancer survivors without shoulder joint motion restriction
Control groupmeasurement of pain pressure thresholdBreast cancer survivors without shoulder joint motion restriction
Experimental Groupmeasurement of grip strengthBreast cancer survivors with shoulder joint motion restriction
Experimental Groupmeasurement of skin temperatureBreast cancer survivors with shoulder joint motion restriction
Experimental Groupmeasurement of pain pressure thresholdBreast cancer survivors with shoulder joint motion restriction
Control groupmeasurement of the range of shoulder joint motionBreast cancer survivors without shoulder joint motion restriction
Control groupmeasurement of passive muscle tone (Hz)Breast cancer survivors without shoulder joint motion restriction
Control groupmeasurement of creep of tissueBreast cancer survivors without shoulder joint motion restriction
Control groupmeasurement of grip strengthBreast cancer survivors without shoulder joint motion restriction
Primary Outcome Measures
NameTimeMethod
measurement of the range of shoulder joint motionBaseline

The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.

measurement of tissue stiffness (N/m)Baseline

Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of passive muscle tone (Hz)Baseline

muscle tones will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of creep of tissueBaseline

creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain

Secondary Outcome Measures
NameTimeMethod
measurement of grip strengthBaseline

The grip strength of both hand will be evaluated by "hand-held" dynamometer.

measurement of painBaseline

Pain will be evaluated by visual analog scale (VAS). In the scale, the patient is asked to mark the most appropriate pain intensity on a scale ranging from 0 (no pain) to 10 (tolerable pain). The higher the score, the greater the pain intensity.

measurement of skin temperatureBaseline

measurements will be taken from the area covering 3 cm of the surgical incision with a P45 thermographic camera with high thermal sensitivity

measurement of pain pressure thresholdBaseline

Pain pressure threshold will be evaluated by a digital algometer

Trial Locations

Locations (1)

İstanbul Medeniyet University

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath